Suchergebnisse - "Tabak, Fehmi"

PubPharm (5)

1

Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B

enthalten in: Alimentary pharmacology & therapeutics | 2019

von Liem, K. | van Campenhout, M. | Xie, Q. | +7

CommentIn: Aliment Pharmacol Ther. 2019 Mar;49(5):609-610. - PMID 30746775

2

Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection : ARES long-term follow-up

enthalten in: Journal of viral hepatitis | 2019

von van Campenhout, M. | Brouwer, W. | Xie, Q. | +18

3

A long-term multicenter study : Entecavir versus Tenofovir in treatment of nucleos(t)ide analogue-naive chronic hepatitis B patients

enthalten in: Clinics and research in hepatology and gastroenterology | 2018

von Kayaaslan, B. | Akinci, E. | Ari, A. | +6

4

Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B : A multicenter randomized trial (ARES study)

enthalten in: Hepatology (Baltimore, Md.) | 2015

von Brouwer, W. | Xie, Q. | Sonneveld, M. | +17

CommentIn: Hepatology. 2015 May;61(5):1459-61. - PMID 25645624

5

First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment

enthalten in: European journal of gastroenterology & hepatology | 2014

von Ozaras, R. | Mete, B. | Ceylan, B. | +9

1
[1]